Search

Your search keyword '"Volpi, S"' showing total 445 results

Search Constraints

Start Over You searched for: Author "Volpi, S" Remove constraint Author: "Volpi, S"
445 results on '"Volpi, S"'

Search Results

4. Les mutations gain de fonction de TLR7 sont à l’origine d’une maladie systémique et neuro-inflammatoire

5. POS0773 STRATIFICATION OF PEDIATRIC SAPHO SYNDROME BASED ON SKIN MANIFESTATIONS: RESULTS FROM AN ITALIAN MULTICENTRIC STUDY (SAPHOPED)

6. OA11.05 A Propensity-Matched Comparison between Minimally Invasive Surgery and Stereotactic Radiotherapy in the Treatment of Clinical Stage I NSCLC

13. 28. Creation of a national in-training examination in radiation oncology: Impact evaluation

14. 623 Preliminary assessment of nasal and colon-derived primary cells theratyping for a personalized medicine approach in people with cystic fibrosis carrying ultra-rare genotypes

15. 509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis

17. Expanding the clinical and neuroimaging features of post-varicella arteriopathy of childhood

19. P027 Effects of ivacaftor therapy confirm the results of theratyping using rectal and nasal epithelial cells of a cystic fibrosis patient carrying the ultra-rare CFTR genotype W57G (c.169T > G)/A234D (c.701C > A)

21. Hypokalemia in Patients with COVID-19

22. Deficiency in coatomer complex I causes aberrant activation of STING signalling

23. Evidence for charge-based mimicry in anti dsDNA antibody generation

26. Inherited defects in the complement system

27. First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy

28. Immunological basis of virus-host interaction in COVID-19

29. Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis

30. Primary atopic disorders and chronic skin disease

31. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

33. Corrigendum to ‘SJS/TEN 2019: From science to translation’ [J. Dermatol. Sci. 98/1 (2020) 2–12]

34. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study

35. Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis

36. Neutrophil Extracellular Traps in the Autoimmunity Context

37. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis

38. Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multicenter Pilot for Preemptive Pharmacogenomics in Electronic Health Record Systems

42. Recurrence of previous chilblain lesions during the second wave of COVID‐19: can we still doubt the correlation with SARS‐CoV‐2?

44. Serum IgG2 antibody multi composition in systemic lupus erythematosus and in lupus nephritis

45. SJS/TEN 2019: From Science to Translation

46. Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic

47. Psycho-social characteristics in patients with discopathy: Quality of Life, coping strategy and mood state

49. P183 Increase of HLA-G in plasma of cystic fibrosis paediatric patients treated with Docosahexaenoic acid (DHA)

50. THU0501 EARLY DIAGNOSIS OF THE AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) IN PATIENTS WITH UNDEFINED AUTOINFLAMMATORY OR AUTOIMMUNE DISORDERS: THE PRACTICAL ROLE OF A FLOW CYTOMETRY PANEL

Catalog

Books, media, physical & digital resources